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Abstract
Objective: To assess the diagnostic accuracy of different cut-off values of pleural fluid adenosine deaminase levels
as a diagnostic method for tuberculous pleural effusion.
Method: The prospective study was conducted from 2014 to 2016 at the Aga Khan University Hospital, Karachi, and
comprised pleural fluid samples of adult patients with and without tuberculosis which were tested for adenosine
deaminase levels, and divided into tuberculosis group A and non-tuberculosis group B. Sensitivity, specificity,
negative predictive value and positive predictive value were calculated using different cut-offs. Data was analysed
using IBM SPSS (Statistical Package for Social Sciences) version 21.0 (IBM Corp., Armonk, NY).
Results: Of 155 patients, 46(29.7%) had tuberculosis; 30(65.2%) males and 16(34.8%) females. Those who did not
have tuberculosis were 109(70.3%); 69(63.3%) males and 40(36.7%) females. The adenosine deaminase levels were
elevated in group A compared to group B (p<0.001). The cut-off of 30U/L showed the highest sensitivity (71.7%) and
negative predictive value (87.4%), and a specificity of 82.6%. The cut-off of 50U/L showed the highest specificity
(89.9%) with sensitivity 52.2%, and the cut-off of 40U/L showed the highest positive predictive value of 68.9% with
sensitivity 67.4% and specificity 87.2%.
Conclusion: Pleural fluid adenosine deaminase testing for diagnosing tuberculosis pleuritis revealed highest
sensitivity and moderate specificity for cut-off value of 30U/L.
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Introduction
Tuberculosis (TB) is one of the leading infectious causes of
morbidity and mortality worldwide. In 2018 there were 10
million new cases and 1.45 million deaths caused by TB
globally.1 In Pakistan, the estimated incidence reported
was 562,000 (265/100,000) and 44,000 patients died in
2018.1 Pulmonary TB is the most common form of TB, but
other parts of the body can also be affected by
Mycobacterium tuberculosis (MTB) (extra-pulmonary TB).2
One of the more common manifestations of extrapulmonary TB (EPTB) is pleural TB which accounts for
pleural effusion in up to 25% TB patients.3 A delayed type
hypersensitivity reaction in response to rupture of subpleural focus of MTB infection that increases vascular
permeability has been noted to be the cause of TB
effusion.4
Patients with pleural TB mostly present with fever, cough
and pleuritic chest pain.5 Pleural TB is usually diagnosed
by pleural fluid microscopy or culture of acid-fast bacilli
(AFB) or by pleural biopsy. Caseating granulomas are the
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characteristic finding on histopathology.6,7 However,
these methods are not only invasive, but also timeconsuming.8 It takes around 4-6 weeks for culture results
to be reported which has an impact on immediate clinical
decisions to be taken, differentials to be ruled out, and
ultimately delay in timely treatment.8 Moreover,
specimens from pleural space have a low bacillary burden
and decreases the sensitivity of culture results.8
Due to the lack of sensitivity of diagnostic assays and
relative difficulty in pleural tissue sampling compared to
thoracentesis, biomarkers are being increasingly looked
upon in pleural effusions of patients with TB.8,9 Among
many biomarkers identified, adenosine deaminase (ADA),
an enzyme that converts (deoxy)adenosine to
(deoxy)inosine, was found to be the most relevant marker
to be used as a diagnostic tool.10 ADA has two isoenzymes;
ADA-1, which is present in almost all cells, and ADA-2,
which is mainly expressed in monocytes and macrophages
and is released following intracellular infection.11 Activity of
both isoenzymes is increased in pleural TB, but
predominantly in ADA-2.11 ADA helps monocytes to
mature into macrophages and is also known to be
responsible for proliferation and differentiation of
lymphoid cells, especially T cells, and is shown to
contribute in purine metabolism.12 Hence, ADA is an
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essential component of cellular immunity.12 Previous
studies have shown that activity of ADA increases in pleural
effusions of patients with TB because of mycobacterial
stimulation of T cells, therefore, ADA has been proposed to
be a potential marker for the detection of TB in body fluids,
such as pleural, pericardial and peritoneal fluid.13
Multiple studies have favoured the utilisation of ADA
measurement as a quick, simple and low-cost diagnostic
tool for pleural TB with high sensitivity and specificity.11
Meta-analyses from different countries have revealed
high mean sensitivity (ranging 90-94%) and specificity
values (88-92%).10,14-16 Diagnostic ADA levels have also
been correlated with age, with 72U/L for those aged 55
years or below, and 26U/L for those >55 years.17
The current study was planned to assess the sensitivity
and specificity of different cut-off values of pleural fluid
ADA levels for the diagnosis of TB effusion in suspected
patients in a high-burden country.

Patients and Methods
The prospective study was conducted from 2014 to 2016 at
the Aga Khan University Hospital, Karachi after receiving
approval from the institutional ethics review committee.
The sample size was calculated using PASS (Power Analysis
and Sample Size Software) version 13.0 (NCSS, LLC. Kaysville,
Utah, USA). It was determined with 80% power using a twosided binomial test comparing sensitivities of 0.50 and 0.75
under the null and alternate hypotheses, respectively. The
sample size was also calculated with 100% power using a
two-sided binomial test comparing specificities of 0.50 and
0.85 under the null and alternate hypotheses, respectively.
The target significance level was 0.05 for both tests. The
actual significance level achieved by the sensitivity test and
specificity test was 0.026 and 0.035, respectively. The
prevalence of tuberculous plural effusion was 29.7%. For
sample size calculation, sensitivity and specificity of 0.75
and 0.85 respectively, were assumed to match the lowest
values observed in previously available literature from this
region in order to obtain the highest sample size.14,18 Nonprobability sampling technique was used. Adult patients
with and without TB were included, while patients with
transudate pleural effusion were excluded.
After taking written informed consent from the subjects,
diagnosis of TB effusion was made on the basis of criteria
mentioned in literature.19 Pleural fluid AFB smear or
culture positive, and/or caseating granuloma on pleural
biopsy. Alternatively, clinical features indicative of TB
(fever and/or cough >3 weeks, night sweats, weight-loss),
signs of pleural effusion on chest examination, and chest
X-ray showing pleural effusion; exudative lymphocytic
pleural effusion on pleural fluid analysis as per Light's
Open Access

criteria;20 and treatment response assessment which was
done at 2 months and 6 months of anti-TB therapy in
patients with clinically diagnosed TB effusion. Criteria for
successful treatment was resolution of symptoms and
resolution of effusion on chest X-ray.
Pleural fluid samples of the subjects were tested for
adenosine deaminase levels tested for ADA levels. Results of
ADA were blinded to avoid bias in the determination of
patients' clinical diagnoses. The subjects were subsequently
divided into TB group A and non-TB group B. Demographic,
clinical and microbiological data was recorded.
For specimen processing, an aliquot of pleural fluid from
each sample for ADA activity was centrifuged at 2,000
RPM for 10 minutes. Supernatant was separated and
stored at -80oC until further processing.21
ADA levels were determined using Adenosine Deaminase
Assay Kit (Diazyme Laboratories, San Diego, CA, USA) as
per the manufacturer's instructions in pleural fluid
samples stored at -80°C. The assay used was based on
Berthelot reaction, as described by Giusti and Galanti.22
The cut-off defined by the manufacturer for a positive
result was 30U/L where one unit of ADA corresponded to
the amount of enzymatic activity required to release
1μmol of ammonia per minute from adenosine under
defined conditions.21
Data was analysed using IBM SPSS (Statistical Package for
Social Sciences) version 21.0 (IBM Corp., Armonk, NY) and
Graphpad PRISM. Data was presented as mean values
with standard deviation (SD). Student's t test and MannWhitney U test were used to compare the groups. The
optimal cut-off value for ADA was taken as 30U/L.
Predictive value analyses were performed using MedCalc
20.110 (MedCalc Software, Ostend, Belgium). P<0.05 was
considered statistically significant.

Results
Of 155 patients, 46(29.7%) had TB; 30(65.2%) males and
16(34.8%) females. Those who did not have TB were
109(70.3%); 69(63.3%) males and 40(36.7%) females. Within
group A, 20(43.5%) cases had TB diagnosis microbiologically
confirmed, and 26(56.5%) were clinically diagnosed.
Besides, a decreased trend of total leucocyte count was
observed in group A patients compared to group B; protein
levels were significantly raised in group A compared to
group B (p<0.001); glucose levels were lower in group A
(p>0.05), and there was increased lactate dehydrogenase
(LDH) activity in group A compared to group B (Table-1).
ADA levels were elevated in group A 72.17±68.13
compared to group B 23.21±36.54 (p<0.001) (Figure).
J Pak Med Assoc
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87.2% (Table-2).

Table-1: Characteristics of study population.
Parameters

Non-TB (n=109) TB (n=46)

P value

Age (Years) (mean±SD)
51.4±21.9
46.6±19.6
0.207
Gender
0.821
Male (n=99)
69 (63.3%)
30 (65.2%)
Female (n=56)
40 (36.7%)
16 (34.8%)
Pleural fluid protein concentration (g/dl) 4353.8±1024.0 5030.2±881.7 <0.001
Pleural fluid LDH (IU/L)
901.2±1459.0 4226.7±12202.8 0.142
Total leucocyte count (cells/mm3)
11.7±11.7
8.2±4.6
0.076
Pleural fluid glucose concentration (g/dl) 107.9±62.4
86.8±48.3
0.057
TB: Tuberculosis, M:F: Male:female, LDH: Lactate dehydrogenase test. SD: Standard deviation.
Statistical analysis was done using t test. P values <0.05 were considered statistically significant.

The cut-off of 30U/L showed the highest sensitivity
(71.7%) and negative predictive value (NPV) (87.4%), and
a specificity of 82.6%. The cut-off of 50U/L showed the
highest specificity (89.9%) with sensitivity 52.2%, and the
cut-off of 40U/L showed the highest positive predictive
value (PPV) of 68.9% with sensitivity 67.4% and specificity

Figure: Adenosine deaminase (ADA) activity in tuberculous (TB) and non-TB pleural
effusions; Box and whiskers plots indicate data between 10th and 90th percentiles with
median values of each group represented by a horizontal line. '*' denotes statistically
significant differences (p<0.05) between the two groups.

Discussion
Among other findings, the current study favoured a cut-off
value of 30U/L in terms of diagnostic accuracy of pleural
fluid ADA levels as a diagnostic method for TB pleural
effusion. A broad range of cut-off values have been
described in literature, but the most commonly used
threshold has been between 30U/L and 60 U/L.9,15 The cutoff in the current study was lower because the population
was highly predictive of TB. A meta-analysis of studies
conducted in Spain revealed a high sensitivity (93%) and
specificity (92%) with no significant differences detected
for different cut-off values ranging from 23-35U/L to 4345U/L.10 A meta-analysis of Brazilian studies on the subject
stated a mean sensitivity value of 91.8% and a mean
specificity value of 88.4% with ADA cut-off values ranging
from 30U/L to 60U/L (mean: 40.7 U/L).16 Another metaanalysis of Indian studies gave a pooled estimate of 94%
and 89% for sensitivity and specificity, respectively.14
Suggesting that ADA thresholds of 38-42U/L were more
useful for excluding disease, and thresholds >42U/L were
more useful as a confirmatory marker, the study was unable
to comment on the diagnostic performance of high ADA
levels.14 Similar estimates were seen in other meta-analyses
of global data.15,23 To further emphasise on South Asian
population, a recent study in India showed sensitivity and
specificity of 93.8% and 93.2% respectively when ADA
levels were measured in patients suspected of TB pleuritic,
and the cut-off was set at 40U/L.24 A study in Nepal showed
sensitivity and specificity of 76.1% and 100% respectively
using ADA as a diagnostic test in pleural fluid specimens of
patients with TB compared with study subjects with other
respiratory diseases when a cut-off of 45U/L was used.18
The variation in the results of the current study compared
to other studies could be due to different methods used
or different cut-offs set for analysis of results by different
groups. The characteristics of the population studied also
has an impact on the results obtained.
The diagnostic accuracy of ADA can be enhanced by

Table-2: Diagnostic accuracy of various cut-off values of adenosine deaminase (ADA) in diagnosing pleural tuberculosis (TB).

Statistic

Cutoff 30 U/L
Value
95% CI

Sensitivity
71.7%
Specificity
82.6 %
Positive Predictive Value 63.5%
Negative Predictive Value 87.4 %
Accuracy
79.4%
Youden Index
0.524

56.5% to 84.0%
74.1% to 89.2%
52.6% to 73.1%
81.3% to 91.7%
72.1% to 85.4%
-

Cutoff 35 U/L
value
95% CI

Cutoff 40 U/L
value
95% CI

Cutoff 45 U/L
Value
95% CI

Cutoff 50 U/L
value
95% CI

67.4%
83.5%
63.3%
85.9%
78.7%
0.509

67.4%
87.2%
68.9%
86.4%
81.3%
0.492

52.2%
87.2%
63.2%
81.2%
76.8%
0.403

52.2%
89.9%
68.6%
81.7%
78.7%
0.421

52.0% to 80.5%
75.2% to 89.9%
51.9% to 73.3%
79.9% to 90.3%
71.4% to 84.9%
-

52.0% to 80.5%
79.4% to 92.8%
56.6% to 79.0%
80.6% to 90.6%
74.3% to 87.1%

37.0% to 67.1%
79.4% to 92.8%
49.4% to 75.0%
76.0% to 85.5%
69.3% to 83.2%
-

37.0% to 67.1%
82.7% to 94.9%
53.9% to 80.3%
76.6% to 85.8%
71.4% to 84.9%
-

CI: Confidence interval.
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using different ADA isoenzymes. ADA-1 is increased in
bacterial empyema and ADA-2 is more increased in TB
effusions. Utilisation of ADA-2 can increase the specificity
of ADA for TB diagnosis.11
The current study has its limitations as it was conducted in
a single tertiary care hospital in Karachi. Since it is a
private hospital, the patient population belongs to upper
social classes and the complexity of the cases might not
be the same. Hence, the findings might not be truly
representative of the entire population. Additionally, the
study had a relatively small sample. Large-scale, multicentre studies are needed to evaluate the more sensitive
and specific ADA cut-off level for diagnosing TB pleuritis.

9.

10.

11.

12.

Conclusion
Pleural fluid ADA testing for diagnosing TB pleuritis revealed
highest sensitivity and moderate specificity for cut-off value
of 30U/L. Considering that different ADA isozymes are
elevated in different pathologies, with ADA-2 predominantly
increased in TB effusions, the diagnostic accuracy of pleural
fluid ADA testing in patients with TB pleuritis can be
potentially increased by using ADA-2 values instead.
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